BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28260088)

  • 1. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
    Wang L; Qu J; Zhou L; Liao F; Wang J
    Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
    Wu J; Weng Y; He F; Liang D; Cai L
    Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF; Zhang JG; Guo TX; Pan XJ
    Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-338 regulates NFATc1 expression and inhibits the proliferation and epithelial-mesenchymal transition of human non-small-cell lung cancer cells.
    He W; Lu J
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1091. PubMed ID: 31823518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
    Fan MJ; Zhong YH; Shen W; Yuan KF; Zhao GH; Zhang Y; Wang SK
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2642-2649. PubMed ID: 28678320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.